Disc Medicine, Inc. (IRON)
61.18
+0.84
(+1.39%)
USD |
NASDAQ |
Mar 06, 16:00
67.25
+6.07
(+9.92%)
After-Hours: 20:00
Disc Medicine Free Cash Flow : -181.33M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly & Co. | 5.964B |
| Boston Scientific Corp. | 3.658B |
| Penumbra, Inc. | 174.93M |
| Rapt Therapeutics, Inc. | -86.66M |
| Amylyx Pharmaceuticals, Inc. | -123.48M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -43.30M |
| Cash from Investing (Quarterly) | -222.89M |
| Cash from Financing (Quarterly) | 216.68M |
| Free Cash Flow Per Share (Quarterly) | -1.158 |
| Free Cash Flow to Equity (Quarterly) | -43.37M |
| Free Cash Flow to Firm (Quarterly) | -42.44M |
| Free Cash Flow Yield | -8.41% |